stockrowAquestive Therapeutics, Inc. (AQST) vs Tilray Brands, Inc. (TLRY)
- Aquestive Therapeutics, Inc. AQST 3.64 −4.21%
- Tilray Brands, Inc. TLRY 2.81 −5.07%
Aquestive Therapeutics, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. is the larger, with a market value of $460.0M against $415.3M — 1.1× the size. Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against 12.5%. Tilray Brands, Inc. has the higher net margin (−17.1% vs −162.3%) and the lower return on invested capital (−3.21% vs 0.00%). Across the 17 metrics below, Tilray Brands, Inc. leads on 9 and Aquestive Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | AQST | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.34% | 29.12% | 53.51% |
| Operating margin | (114.12%) | (9.26%) | 0.00% |
| Net margin | (162.33%) | (17.05%) | (2.45%) |
| Free cash flow margin | (83.33%) | (19.10%) | 0.00% |
| Return on equity | 211.59% | (10.50%) | (0.80%) |
| Return on assets | (56.05%) | (7.45%) | (1.67%) |
| Return on invested capital | 0.00% | (3.21%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack